Latest Corporate News News
IMF Raises 2026 Global Growth Forecast to 3.3%
The International Monetary Fund upgraded its 2026 global growth forecast to 3.3%, up 20 basis points from October, driven by surging AI investments offsetting trade disruptions. India's growth outlook rose sharply to 7.3% for FY26 on strong earnings. The fund notes resilience despite tariff shocks but warns of AI and trade risks.
Boston Scientific Acquires Penumbra for $14.5 Billion
Boston Scientific entered a merger agreement on January 15, 2026, to acquire medtech firm Penumbra in its largest deal in 20 years, expanding neurovascular portfolio for blood clots and strokes. The $14.5B transaction is the first major healthcare M&A of 2026, with expectations of more deals amid easier regulations. It was highlighted at the JP Morgan Healthcare Conference.
AbbVie Licenses RemeGen’s RC148 for $5.6 Billion
AbbVie announced a $5.6 billion licensing agreement at the 2026 JP Morgan Conference to develop and commercialize RemeGen’s bispecific antibody RC148 for advanced solid tumors. This bolsters AbbVie's oncology pipeline through manufacturing and global rights. It ranks among the largest deals from the event.
Novartis Strikes $1.6 Billion Alzheimer’s Deal with SciNeuro
Novartis entered a $1.6 billion licensing agreement with SciNeuro Pharmaceuticals for de novo amyloid beta antibody candidates targeting Alzheimer’s disease. The deal enhances Novartis' neuroscience portfolio. It was a key announcement at the JP Morgan Healthcare Conference.
Worthington Steel Completes Kloeckner Takeover
Worthington Steel finalized its takeover of Kloeckner & Co on January 15, 2026, creating North America's second-largest steel service center with $9.5B revenue. The deal, two years in planning, offers $150M annual synergies mainly in North America and triples Worthington's scale. It follows intense steel industry M&A.
Novartis Licenses Oncology Drug from Zonsen PepLib for $50 Million
Novartis signed a $50 million worldwide license with Zonsen PepLib Biotech for a peptide-based radioligand therapy in oncology. This expands Novartis' cancer treatment options globally. The agreement was revealed at the JP Morgan Conference.
Oak Hill Sells Metronet to T-Mobile and KKR JV
Oak Hill Capital sold fiber-to-the-home provider Metronet to a T-Mobile and KKR joint venture, marking a significant telecom infrastructure deal. This transaction highlights ongoing M&A in communications. It positions the buyer to expand high-speed internet access.
Warburg Pincus and Berkshire Complete TRIUMPH Take-Private
Warburg Pincus and Berkshire Partners completed the take-private of TRIUMPH Group, allowing it to operate independently post-transaction. The deal underscores private equity activity in aerospace and defense. It follows a pattern of strategic buyouts.
IBM Acquires AI Consultancy Hakkoda
IBM acquired Hakkoda to enhance its cloud data migration and AI transformation capabilities. The move strengthens IBM's position in enterprise AI services. It reflects tech giants' push into AI-driven consulting.
Pinnacle and Synovus Announce $8.6 Billion Merger
Pinnacle Financial and Synovus agreed to an $8.6B all-stock merger, with Synovus CEO Kevin Blair leading the combined firm and Pinnacle's Terry Turner as chairman. This banking consolidation boosts regional presence. It aims for operational efficiencies in financial services.
Leonardo Acquires Enterprise Electronics Corporation
Leonardo expanded its U.S. footprint by acquiring Enterprise Electronics Corporation through subsidiary Leonardo US Holding on January 19, 2026. The deal bolsters Leonardo's defense and electronics capabilities in America. It supports growth in key markets.
Global Stocks Poised for 2026 Rally, US May Lead
S&P Global predicts international stocks will rally in 2026 but may trail U.S. equities due to AI dominance and liquidity. Emerging markets like India could outperform with discounted valuations and fiscal prudence. European tech, defense, and healthcare offer opportunities.